The Ohio State Comprehensive Cancer Center
The Ohio State Comprehensive Cancer Center
Columbus, Ohio, United States2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) | Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 2 / Phase 3 | 2026-07-17 | NCT02598661 | |
| Ribociclib and Letrozole Treatment in Ovarian Cancer | Cystadenocarcinoma, Serous, Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystadenocarcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2025-12-23 | NCT03673124 |